South Africa will put on hold use of AstraZeneca’s Covid-19 shot in its vaccination programme, after data showed it gave minimal protection against mild-to-moderate infection caused by the country’s dominant coronavirus variant. Health Minister Zweli Mkhize said on Sunday that the government would await advice from scientists on how best to proceed, after a trial showed the AstraZeneca vaccine did not significantly reduce the risk of mild or moderate Covid-19 from the 501Y.V2 variant that caused a second wave of infections starting late last year. Prior to widespread circulation of the more contagious variant, the vaccine was showing efficacy of …read more
Source: Sott health news feed
Thanks! Share it with your friends!
Tweet
Share
Pin It
LinkedIn
Google+
Reddit
Tumblr